RSS Alerts

Share

More services

Related Links

Related Stories

  • Catching up on Circulating Tumor Cell Technology
    Circulating tumor cells (CTCs) are cells that ‘escape’ from primary tumor cells and migrate into the bloodstream, where they circulate through the body. CTCs were first identified in the 1980s as cells that had the morphology of tumor cells but were found in the blood. Over the past two decades technological innovations have eased the detection and analysis of CTCs. The resulting investigations of CTCs are an important area of clinical research because they are demonstrating that CTCs have potential clinical value as warning signals of cancer progression.
  • Lack of alignment threatens drug discovery process
    With looming patient cliffs, drying pipelines and the need for open collaboration, now more than ever the pharma sector needs a co-ordinated approach to get back on track, says a leading industry player.
  • RNID ‘TRIH’ TO ACCELERATE CURES FOR HEARING LOSS AND TINNITUS THROUGH PIONEERING NEW INITIATIVE
    New medicines to prevent and treat hearing loss or tinnitus could be available within 10 years, if a bold new initiative by RNID succeeds in bringing scientists, pharmaceutical companies, funding bodies and private investors together to accelerate clinical trials.
  • The View From Here: Biomarkers in clinical development and commercialization: practice and promise
    Biomarker research and implementation is a hot topic for the pharmaceutical industry. While the positive potential of incorporating biomarker work during development is evident, the field has not reached its full potential.
  • RNID calls on industry to invest in treatments for hearing loss
    Hearing loss charity, RNID, is travelling to Chicago to launch a special issue of Drug Discovery Today at BIO International, the world’s largest biotechnology conference. RNID will be exhibiting at booth number 4707 Produced in association with RNID and Fight for Sight, the publication highlights the exciting progress being made in developing treatments for hearing and vision loss.

Top 5 Stories

News

Caliper integrated robotic system featured in TIME Magazine's Top 10 Scientific Discoveries of 2009

25 January 2010

'The Robot Scientist' first to complete experimentation cycle without human involvement.

Caliper Life Sciences, a provider of life sciences tools, announced recently that TIME Magazine's no. 4 Top Scientific Discovery of 2009 included an integrated robotic system designed by Caliper's Automation, Consulting, Engineering, & Services (ACES) team.

Conceived by Dr Ross King at Aberystwyth University in Wales, the integrated robotic system known as ‘Adam, the Robot Scientist’ identified the role and function of nearly a dozen previously uncharacterized yeast genes. This achievement, initially published in the journal Science, marks the first time a robot with virtually no human intervention completed the cycle of the scientific method: formulation of a hypothesis, experimental design and execution, data interpretation, and revision of the original hypothesis.

‘This outstanding achievement highlights the potential of laboratory automation,’ said Kevin Hrusovsky, CEO of Caliper Life Sciences. ‘Our ACES team is uniquely capable of designing and building solutions to meet and exceed the most complex requirements. As a pioneer in laboratory automation, Caliper has a long history of helping researchers improve laboratory efficiency and shape the future of scientific discovery.’

 

This article is featured in:
Informatics

 

Comment on this article

You must be registered and logged in to leave a comment about this article.

Copyright © 2012
Elsevier Ltd. All rights reserved.
Terms & Conditions | Privacy | Website Design Working with water